Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

AstraZeneca, Corning And More On CNBC's 'Final Trades'

Konskie,,Poland,-,January,03,,2024:,Astrazeneca,Plc,Company,Logo

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner at Cerity Partners, named AstraZeneca PLC (NASDAQ:AZN) as his final trade.

On Aug. 20, AstraZeneca released complete results from the ​BaxHTN Phase 3 trial evaluating ​baxdrostat. The Cambridge, U.K.-based company released the topline data in July.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.